Production (Stage)
Eastwood Bio-Medical Canada Inc.
EBM.V
TSX
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 74.61% | -35.31% | 11.99% | -138.56% | 70.38% |
| Total Depreciation and Amortization | 56.44% | 3.59% | -0.51% | -0.51% | -1.01% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 193.22% | -186.76% | 0.00% | -11.69% | 144.25% |
| Change in Net Operating Assets | -105.53% | 107.73% | -41.85% | 560.17% | -91.27% |
| Cash from Operations | 150.00% | 54.69% | -250.59% | 1,044.44% | -147.37% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -87.97% | 1,868.42% | -- | -- | -- |
| Total Debt Repaid | -- | -314.63% | 320.43% | 16.96% | 78.04% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 166.67% | -129.27% | 337.68% | 16.87% | -176.67% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 158.10% | -400.00% | 118.75% | 117.39% | -736.36% |